Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Man... (ct Status 2012 89Table 73: Lutonix the U...)

HOME >> MEDICINE >> TECHNOLOGY

Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers

Date:1/22/2013

ct Status, 2012 89Table 73: Lutonix, the US, Product Status, 2012 89Table 74: In.Pact Pacific Balloon Catheter, the US, Product Status, 2012 90Table 75: Peripheral Vascular Devices Market, M&A, Global, 2008-2011 92

1.2 List of Figures

Figure 1: Peripheral Vascular Devices Market, Global, Revenue ($m), 2004-2011 13Figure 2: Peripheral Vascular Devices Market, Global, Revenue ($m), 2011-2018 15Figure 3: Peripheral Vascular Devices Market, Global, Key Company Shares (%), 2011 17Figure 4: Usage Trends for Inferior Vena Cava Filters, Global, Volume (Absolute Units), 2004-2011 19Figure 5: Peripheral Vascular Devices Market, Germany, Number of Procedures ('000), 2005-2008 20Figure 6: Stent Grafts Market, Global, Volume ('000), 2004-2011 23Figure 7: Increase in the Percentage of Elderly People in the Population, Global (%), 2010-2050 24Figure 8: Stent Grafts Market, Global, Revenue ($m), 2004-2011 26Figure 9: Stent Grafts Market, Global, Revenue ($m), 2011-2018 27Figure 10: Peripheral Vascular Stents Market, Global, Revenue ($m), 2004-2011 28Figure 11: Peripheral Vascular Stents Market, Global, Revenue ($m), 2011-2018 29Figure 12: PTA Balloons Market, Global, Revenue ($m), 2004-2011 30Figure 13: PTA Balloons Market, Global, Revenue ($m), 2011-2018 31Figure 14: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2004-2011 32Figure 15: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2011-2018 33Figure 16: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2004-2011 34Figure 17: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2011-2018 35Figure 18: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2004-2011 36Figure 19: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2011-2018 37Figure 20: Peripheral Guidewires Market, Global, Revenue ($m), 2004-2011 38Figure 21: Peripheral Guidewires Market, Global, Revenue ($m), 2011-2018 39Figure 22: PTA Peripheral Drug-eluting Ball
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
2. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
3. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
4. Global Peripheral Vascular Devices Market 2011-2015
5. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others
6. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
7. European Markets for Peripheral Vascular Devices 2012
8. European Market for Peripheral Vascular Devices
9. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
10. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
11. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications

Post Your Comments:

(Date:5/23/2013)... Hearing health affects a man,s lifestyle, and if he wants ... engaged, he should address any hearing loss he may be ... Hearing Institute (BHI) is delivering to men around the ... which leads up to and includes Father,s Day. This year, ... 16. To help men address their hearing ...

(Date:5/23/2013)... 2013 More than half of women diagnosed ... chemotherapy and still have excellent outcomes. To educate women, ... the largest sources of online consumer information about breast ... page provide recently diagnosed women with information sources, to ... "We anticipate these innovative social media campaigns ...

(Date:5/23/2013)... Mass. , May 23, 2013 Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...

Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3 Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3 First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4

[0] Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises [0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions [0] First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection

... , CAMBRIDGE, Massachusetts, December ... global specialty biopharmaceutical company,today announced that it has submitted a ... therapy for Fabry disease. REPLAGAL,first received marketing authorization in the ... Fabry disease in 45 countries. , ...

... , PITTSBURGH, Dec. 22 Mylan Inc. ... Laboratories Limited has received tentative approval from the U.S. Food ... AIDS Relief (PEPFAR) for its New Drug Application (NDA) for ... innovative pediatric dosages in tablet form were developed by Matrix ...

Cached Medicine Technology:Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) 2 Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) 3 Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) 4 Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA) 5 Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets 2

Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets

(Date:5/25/2013)... 25, 2013 By working diligently for ... the integration of the 2012 Lamborghini Aventador into their ... latest entrant in the list of vehicles lined by ... is all set to thrill automobile lovers in the ... and spectacular looks, the 2012 Lamborghini Aventador comes with ...

(Date:5/25/2013)... 25, 2013 Dr. Farooq Ashraf, founder ... in Dubai, has announced his practice’s adoption of The ... only FDA-cleared femtosecond laser proven with more than 10 ... precision of LASIK. , “We are happy to announce ... Laser at our Dubai LASIK practice,” Ashraf said Thursday. ...

(Date:5/25/2013)... IBISWorld estimates that revenue for the ... rate of 28.7% to $1.0 billion in the five years ... and 2008, no new cell therapy products were introduced, according ... during that period. In the years since, however, the Food ... factor contributed to the industry's fast growth during the five ...

(Date:5/25/2013)... 2013 Ayurveda is the traditional ... or wisdom of life". While a medical science, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... It believes that in order to re-establish optimal health, we ... then adopt a life style which brings us back into ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html ... of a judge's overturning of a jury's award of ... the first trial* in the country over allegations that ... to court files. , The judge in the case ... to show his cancer was caused by the medication.** ...

Breaking Medicine News(10 mins):Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2 Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3 Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3 Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4

[0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method [0] Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld [0] Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes [0] Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases

... ANN ARBOR, Mich. The majority of parents feel ... for their child, according to researchers at the University ... new study published in the October issue of the ... they participate in decisions made about their hospitalized childs ...

... is one of four oral medications approved by ... the treatment of alcoholism. A recent large ... the National Institute of Alcoholism and Alcohol Abuse ... a modest but significant benefit but another FDA-approved ...

... Administering hydrogen sulfide (H 2 S) directly into the ... tissue and cell damage often seen in oxygen-starved organs, ... University of Alabama at Birmingham. , H 2 S ... an unwanted side effect of restoring blood flow swiftly ...

... talking about peripheral artery disease , , WEDNESDAY, Sept. ... spent decades tickling America,s funny bone and tugging ... health she,s working for now, crisscrossing the country ... and underdiagnosed cardiovascular threat called peripheral artery disease ...

... Clarient, Inc.,(Nasdaq: CLRT ), a premier technology ... today announced,that it is scheduled to make an investor ... 4:30 p.m. EDT on Wednesday, September,26, 2007. The conference ... York City,September 24-27. A live webcast of the ...

... Dairy Commission Supports Emission Limits, Buffer Zones to Protect ... ... Board of,Supervisors decided on Tuesday to defer action on a crucial proposal ... a,Planning Commission meeting-leaving unanswered the question of whether,dairy - - related pollution ...

Cached Medicine News:Health News:Parents' participation in medical decisions linked to self-efficacy 2 Health News:Family history of alcoholism affects response to drug used to treat heavy drinking 2 Health News:Severe heart attack damage limited by hydrogen sulfide 2 Health News:'Cosby' Star Tackles a Silent Heart Threat 2 Health News:'Cosby' Star Tackles a Silent Heart Threat 3 Health News:'Cosby' Star Tackles a Silent Heart Threat 4 Health News:Clarient to Present at the UBS 2007 Global Life Sciences Conference 2 Health News:County Board Punts to Planning Commission On Clean-Air Issue 2

Parents' participation in medical decisions linked to self-efficacy Family history of alcoholism affects response to drug used to treat heavy drinking Severe heart attack damage limited by hydrogen sulfide 'Cosby' Star Tackles a Silent Heart Threat Clarient to Present at the UBS 2007 Global Life Sciences Conference County Board Punts to Planning Commission On Clean-Air Issue

... C-Peptide is devoid of any biological activity ... the structural integrity of insulin. Although insulin ... in equimolar concentrations, fasting levels of C-Peptide ... insulin owing to the longer half-life of ...

Inquire...

Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use....

... Zeus Scientific, Inc. Measles test ... qualitative and quantitative detection of ... by the indirect fluorescent antibody ... determine or confirm recent infection ...

Medicine Products:

C-Peptide ,Chemiluminescence Immunoassay C-Peptide MEASLES (Rubeola) IgG ELISA TEST SYSTEM MEASLES (Rubeola) IgG IFA TEST